9 Prion Disease Symptoms to Recognize

What if symptoms that seem like ordinary memory problems or changes in coordination were actually signs of one of the rarest and most rapidly progressive brain disorders? Although prion diseases are uncommon, they are serious conditions that damage the brain over time and often worsen quickly. Recognizing the early prion disease symptoms can help families seek timely medical evaluation and better understand what may be happening.

Prion diseases are a group of rare, fatal neurodegenerative disorders caused by abnormal prion proteins that trigger healthy proteins in the brain to fold incorrectly. As these abnormal proteins accumulate, they gradually destroy brain tissue, leading to severe neurological decline. Unlike bacteria or viruses, prions are infectious proteins, making these disorders unique among brain diseases.

Fortunately, prion diseases are extremely rare. Worldwide, they affect approximately 1 to 2 people per million each year, which translates to only about 8,000 to 16,000 new cases annually across the globe. The most common form, sporadic Creutzfeldt-Jakob disease (sCJD), accounts for around 85% to 90% of all prion disease cases. Most patients are diagnosed between the ages of 55 and 75, although inherited and acquired forms can occur at different ages.

One of the greatest challenges is that the earliest symptoms may be subtle and resemble more common neurological conditions. People may first notice memory loss, personality or behavioral changes, difficulty concentrating, poor coordination, or vision problems. As the disease progresses, symptoms often worsen rapidly, affecting movement, speech, thinking, and the ability to carry out everyday activities. Because progression can occur over weeks or months rather than years, early recognition is especially important.

In this article, we’ll explore 9 prion disease symptoms, explain why these symptoms develop, and discuss when it’s important to seek medical evaluation. Understanding these warning signs can help raise awareness of this rare but devastating group of neurological disorders.

Table of Contents

9 Early Symptoms of Prion Disease

Rapidly Developing Dementia

Rapidly developing dementia is a swift and severe decline in cognitive functions, including memory, thinking, reasoning, and judgment, that progresses over weeks to months rather than the years typical of other dementias. This symptom is often the most prominent and alarming early sign of prion diseases, particularly sporadic Creutzfeldt-Jakob Disease (sCJD).

Unlike Alzheimer’s disease, where memory loss evolves gradually over a decade or more, the cognitive deterioration in prion disease is relentless and compressed into a much shorter timeframe. An individual who was functioning normally just a few months prior may quickly become unable to perform daily tasks, manage finances, or even recognize loved ones.

More specifically, this cognitive decline is multifaceted and goes beyond simple memory loss. Patients may exhibit a profound inability to plan, organize, or solve problems. Simple, multi-step tasks that were once routine, such as preparing a meal or following directions, become impossible. This loss of executive function is often one of the first signs that something is seriously wrong.

While memory loss is a feature, it is its speed of onset that is characteristic. Short-term memory is typically affected first, leading to repetitive questioning and an inability to retain new information. As the disease advances, long-standing memories also begin to fade.

Individuals may make uncharacteristic and poor decisions related to their safety or finances. They may lose the ability to understand consequences or to think abstractly. This cognitive breakdown is a direct result of the rapid neuronal death occurring in the cerebral cortex, the part of the brain responsible for higher-level thought processes. The swiftness of this decline is a key diagnostic clue that separates prion diseases from other, more common forms of dementia.

Ataxia

Ataxia in the context of prion disease is a severe neurological sign characterized by a loss of coordination and balance, resulting in an unsteady gait, stumbling, and a general inability to control voluntary muscle movements. This symptom arises from damage to the cerebellum, the part of the brain that is crucial for coordinating movement.

As prion proteins accumulate and destroy cerebellar neurons, the brain’s ability to orchestrate smooth, precise movements is progressively lost. Ataxia is a hallmark feature in many forms of prion disease, including CJD, Kuru, and Gerstmann-Sträussler-Scheinker Syndrome, and its presence often prompts physicians to consider a prion-related diagnosis.

The most common sign is a wide-based, staggering walk, often described as drunken in appearance. Individuals may struggle to walk in a straight line, frequently trip over their own feet, or need to hold onto walls and furniture for support. The progression is typically rapid, with a person going from a slight imbalance to being wheelchair-bound or bedridden in a matter of weeks or months.

Ataxia also affects the arms and hands, leading to difficulties with fine motor skills. Tasks like buttoning a shirt, writing, or using utensils become clumsy and eventually impossible. The patient may overshoot when trying to reach for an object (dysmetria) or be unable to perform rapid, alternating movements (dysdiadochokinesia).

The lack of coordination extends to the muscles controlling speech and eye movements. Speech may become slurred, slow, and irregular in rhythm (dysarthria). Eye movements can also become jerky and uncoordinated, leading to nystagmus (involuntary eye movements) or difficulty focusing, which can contribute to vision problems and dizziness.

Myoclonus

Myoclonus refers to sudden, brief, involuntary muscle jerks or twitches that can affect a single muscle or a group of muscles, often appearing as a startling, shock-like contraction. In prion diseases, particularly CJD, myoclonus is a very common and characteristic symptom, occurring in approximately 90% of patients at some point during their illness.

These movements are not under the person’s control and can be triggered by external stimuli such as a loud noise, a sudden touch, or even bright light (startle myoclonus). The presence of myoclonus, especially when combined with rapidly progressive dementia, is a strong indicator of CJD.

More specifically, the jerks can be rhythmic or irregular, symmetrical or asymmetrical. They can be subtle twitches of a finger or facial muscle, or they can be large, violent movements that cause the entire body to jerk, potentially leading to falls and injury. These movements typically become more frequent and pronounced as the disease progresses. They are thought to result from the disruption of normal signaling in the motor cortex and subcortical structures of the brain due to prion-induced damage.

Beyond myoclonus, patients with prion disease may exhibit other types of involuntary movements. These can include chorea (rapid, jerky, dance-like movements), athetosis (slow, writhing movements), and dystonia (sustained muscle contractions causing twisting and repetitive movements or abnormal postures). Tremors, similar to those seen in Parkinson’s disease, may also be present, although they are generally less common than myoclonus.

The combination of different movement disorders can make diagnosis challenging, but the prominence of myoclonus in the setting of rapid cognitive decline is highly suggestive of a prion disease. Neurologists often use an electroencephalogram (EEG) to detect characteristic brain wave patterns, such as periodic sharp wave complexes, which are often associated with myoclonus in CJD patients.

Behavioral Changes

The personality and behavioral changes that occur in prion disease are often profound and uncharacteristic of the individual, including symptoms such as apathy, agitation, anxiety, depression, paranoia, and sudden mood swings. These changes are not simply emotional reactions to the illness but are direct consequences of the neurological damage occurring in brain regions responsible for emotion, behavior, and personality, such as the frontal and limbic lobes.

For families and caregivers, these alterations can be one of the most distressing aspects of the disease, as the person they know seems to disappear, replaced by someone who acts in unfamiliar and sometimes challenging ways.

For example, the spectrum of behavioral symptoms can be broad and vary between individuals. One of the most common early behavioral signs is a marked loss of interest and motivation. A person may become emotionally flat, indifferent to their surroundings, and withdraw from social interactions and activities they once enjoyed. This profound apathy can be mistaken for depression, but it often lacks the deep sadness associated with major depressive disorder.

In contrast to apathy, some individuals may become easily agitated, irritable, or aggressive. They may have outbursts of anger or frustration with little or no provocation. This can be particularly difficult for caregivers to manage and is a reflection of the brain’s diminished capacity for emotional regulation and impulse control.

Prion diseases can mimic primary psychiatric disorders, especially in the early stages. Patients may develop paranoia, believing that family members or caregivers are trying to harm them. They might experience delusions (fixed, false beliefs) or hallucinations (seeing or hearing things that are not there). These psychotic symptoms can further complicate the diagnostic process and may initially lead to a misdiagnosis of a psychiatric condition like schizophrenia or severe depression with psychosis.

Confusion

Confusion and disorientation happen in prion disease because the rapid and widespread destruction of neurons impairs the brain’s ability to process information, interpret the environment, and maintain an awareness of time, place, and identity. This is a core feature of the rapidly progressive dementia associated with the condition.

As prions accumulate and create sponge-like holes in brain tissue, critical neural networks responsible for awareness, memory, and spatial navigation break down. The result is a state of profound confusion where the individual struggles to make sense of their surroundings and their own situation.

An early sign is often disorientation to time. The person may not know the correct date, day of the week, or even the current season. This quickly progresses to disorientation to place, where they may not recognize their own home or other familiar environments. They might get lost easily and become unable to navigate even simple routes. This is linked to damage in the parietal and temporal lobes, which are crucial for spatial awareness and memory consolidation.

As the disease advances, patients often lose the ability to recognize familiar faces, including those of close family members and friends. This symptom, known as prosopagnosia, can be incredibly distressing for loved ones. It stems from damage to the regions of the brain responsible for facial processing and linking a face to a stored memory of a person.

Beyond specific disorientation, patients often exist in a general state of confusion and bewilderment. They may struggle to follow conversations, understand simple instructions, or grasp what is happening around them. This pervasive cognitive fog is a direct result of the global brain dysfunction caused by the relentless progression of the prion pathology, which disrupts communication between different brain areas.

Vision Problems

Vision problems associated with prion disease include blurred or double vision, changes in visual perception, visual hallucinations, and cortical blindness, all of which stem from damage to the occipital lobes and other parts of the brain’s visual processing pathways.

While eye problems are not always the first symptom, they are a significant feature in a subset of CJD cases, sometimes referred to as the Heidenhain variant, where visual disturbances are the dominant initial sign. These issues are not caused by a problem with the eyes themselves but by the brain’s inability to correctly interpret the signals being sent from the eyes.

Patients may complain of blurry vision that cannot be corrected with glasses. They might experience diplopia (double vision) or have difficulty with depth perception, making it hard to judge distances. Some individuals develop visual field defects, where they lose sight in parts of their visual field. They might also have trouble recognizing objects or colors, a condition known as visual agnosia.

Seeing things that are not there is another potential symptom. These hallucinations can be simple, such as seeing flashing lights, patterns, or colors, or they can be complex, involving detailed images of people, animals, or scenes. These experiences are generated internally by the damaged brain and can be frightening and confusing for the patient.

In severe cases, the damage to the occipital lobes—the brain’s primary visual processing center—can be so extensive that it leads to cortical blindness. In this condition, the eyes are perfectly healthy and capable of receiving visual information, but the brain can no longer process the signals into images. The person is functionally blind, even though their eyes are intact. This represents a catastrophic failure of the brain’s visual system due to prion-induced neurodegeneration.

Insomnia

The nature of insomnia in prion disease is a severe, intractable, and progressive inability to sleep that goes far beyond typical sleep disturbances, ultimately leading to a complete breakdown of the sleep-wake cycle. This symptom is the defining characteristic of a specific hereditary prion disease called Fatal Familial Insomnia (FFI).

However, significant sleep disruption can also occur in other forms of prion disease, such as CJD. In FFI, the insomnia is not merely a symptom but the central feature of the illness, caused by profound damage to the thalamus, a brain region critical for regulating sleep and consciousness.

The illness often begins with increasing difficulty falling asleep and staying asleep. Over a period of months, this progresses until the patient can only achieve brief, fragmented periods of a dream-like state that lacks the restorative qualities of true sleep. Eventually, the ability to sleep is lost almost entirely. This chronic sleep deprivation has catastrophic effects on the body and mind, contributing to cognitive decline, motor dysfunction, and autonomic instability.

The thalamic damage in FFI also disrupts the autonomic nervous system, which controls involuntary bodily functions. This leads to symptoms such as high blood pressure, increased heart rate, excessive sweating, and fever. The body essentially enters a state of constant, heightened alertness from which it cannot escape, further preventing any possibility of restful sleep.

The relentless lack of sleep, combined with direct prion damage, leads to a rapid decline in physical and mental function. Patients develop ataxia, myoclonus, and dementia. The combination of sleep deprivation and neurodegeneration creates a vicious cycle that accelerates the progression of the disease, leading to death, typically within 7 to 36 months from onset.

Dysphasia

Dysphasia, also known as aphasia, is a language disorder characterized by difficulty with communication, including problems with speaking, understanding spoken language, reading, and writing.

In prion disease, dysphasia arises from the damage to the language centers of the brain, primarily located in the left hemisphere (for most right-handed individuals), such as Broca’s area (responsible for speech production) and Wernicke’s area (responsible for language comprehension). As the disease destroys neurons in these critical regions, the ability to use and understand language progressively deteriorates, leading to significant communication barriers.

More specifically, dysphasia can manifest in several ways depending on the exact location of the brain damage. Expressive dysphasia involves difficulty producing language. The person may know what they want to say but struggle to find the right words (anomia). Their speech may become slow, hesitant, and ungrammatical, often consisting of short, fragmented phrases. In severe cases, they may be able to utter only a few words or may become completely mute. This is often linked to damage in or around Broca’s area in the frontal lobe.

Receptive dysphasia involves difficulty understanding language. The person may hear the words spoken to them but be unable to process their meaning. Their own speech might be fluent and grammatically correct but filled with incorrect, invented, or nonsensical words (neologisms), making it incomprehensible. They are often unaware of their errors and may become frustrated when others cannot understand them. This is typically associated with damage to Wernicke’s area in the temporal lobe.

As the prion disease progresses and damage becomes more widespread, individuals often develop global dysphasia, which is a severe impairment of both the production and comprehension of language. At this stage, the person has profound difficulty communicating in any form, effectively isolating them and creating immense challenges for care.

Dysphagia

Dysphagia is the medical term for difficulty swallowing, which can involve problems with moving food or liquid from the mouth to the stomach.

In the context of prion disease, dysphagia is a common and serious symptom that typically emerges in the middle to late stages of the illness. It results from the neurodegeneration affecting the parts of the brain and cranial nerves that control the complex sequence of muscle movements required for a safe and effective swallow. The loss of this vital function poses significant risks, including malnutrition, dehydration, and aspiration pneumonia.

Swallowing involves the coordinated action of over 50 pairs of muscles in the mouth, throat (pharynx), and esophagus. Prion-induced damage to the brainstem and motor cortex disrupts the neural signals that control these muscles. This can lead to a weak or delayed swallowing reflex, poor tongue control, and an inability of the larynx to close properly, which normally protects the airway during swallowing.

The signs of dysphagia can be obvious or subtle. They may include coughing or choking during or after eating and drinking, a gurgly or wet-sounding voice after swallowing, a sensation of food being stuck in the throat, and frequent throat clearing. Patients may take a long time to eat, drool, or have food residue left in their mouths after a meal.

The most dangerous complication of dysphagia is aspiration, where food, liquid, or saliva enters the airway and lungs instead of the esophagus. This can lead to aspiration pneumonia, a serious lung infection that is a common cause of death in patients with advanced neurodegenerative diseases. To manage dysphagia, speech-language pathologists may recommend modified food textures (such as pureed foods) and thickened liquids. In advanced stages, when oral intake is no longer safe, a feeding tube may be necessary to provide nutrition and hydration.

What is Prion Disease?

Prion disease is a family of rare, progressive, and fatal neurodegenerative disorders caused by abnormal, misfolded proteins called prions that primarily affect the brain. These conditions, also known as transmissible spongiform encephalopathies (TSEs), are unique because they can be sporadic, hereditary, or acquired.

The defining feature of these diseases is the conversion of a normal cellular protein, called the prion protein (PrP^C), into a toxic, misfolded form (PrP^Sc). This misfolded protein then acts as a template, inducing other normal PrP^C molecules to misfold in a self-perpetuating chain reaction.

This process leads to the accumulation of abnormal protein aggregates in the brain, causing widespread neuronal death and creating a characteristic sponge-like (spongiform) appearance in the brain tissue.

How do Prions Cause Brain Damage?

Prions cause brain damage through a cascade of molecular events initiated by the misfolded prion protein (PrP^Sc), which induces a chain reaction that converts normal prion proteins (PrP^C) into the abnormal form, leading to protein aggregation, neuronal death, and the formation of microscopic holes in the brain.

The normal prion protein, PrP^C, is a common protein found on the surface of cells, particularly neurons, though its exact function is not fully understood. It has a predominantly alpha-helical structure.

The pathogenic form, PrP^Sc, has the same amino acid sequence but is folded differently, with a higher proportion of beta-sheet structures. This altered shape makes it extremely stable, resistant to heat, radiation, and enzymes that normally break down proteins.

More specifically, the process begins when a PrP^Sc molecule comes into contact with a normal PrP^C molecule. The PrP^Sc acts as a template, forcing the PrP^C to refold into the pathogenic PrP^Sc conformation. This newly formed PrP^Sc molecule can then go on to convert more PrP^C proteins. This exponential, self-propagating cycle leads to a rapid accumulation of the abnormal protein within the brain.

The misfolded PrP^Sc proteins are sticky and tend to clump together, forming aggregates. These aggregates can range from small, soluble oligomers to large, insoluble amyloid plaques that deposit in the brain tissue. These protein clumps are toxic to neurons, disrupting cellular function and ultimately triggering programmed cell death (apoptosis).

As neurons die, they leave behind empty spaces, or vacuoles, in the brain tissue. Under a microscope, this gives the brain a characteristic sponge-like appearance, which is why these diseases are called spongiform encephalopathies. In response to the neuronal damage, non-neuronal cells in the brain, such as astrocytes and microglia, become activated in a process called gliosis. While this is an inflammatory response meant to clear cellular debris, the chronic activation contributes to the overall brain damage.

Different Types of Human Prion Diseases

There are several main types of human prion diseases, which are classified based on their origin (sporadic, hereditary, or acquired) and clinical presentation: Creutzfeldt-Jakob Disease (CJD), Variant CJD (vCJD), Kuru, Gerstmann-Sträussler-Scheinker Syndrome (GSS), and Fatal Familial Insomnia (FFI). While all are caused by the same fundamental prion mechanism, they differ in their symptoms, progression, and the populations they affect.

Creutzfeldt-Jakob Disease (CJD) is the most common human prion disease. It is further divided into three forms: sporadic (sCJD), which accounts for about 85% of cases and has no known cause; familial (fCJD), an inherited form caused by a genetic mutation; and iatrogenic (iCJD), which is acquired through contaminated medical procedures. CJD is characterized by rapidly progressive dementia, ataxia, and myoclonus, with death typically occurring within a year of onset.

Variant Creutzfeldt-Jakob Disease (vCJD) is an acquired form linked to the consumption of beef from cattle infected with bovine spongiform encephalopathy (BSE), or “mad cow disease.” It typically affects younger individuals and has a distinct clinical presentation that often begins with psychiatric symptoms like depression and anxiety, followed by neurological signs. The brain pathology of vCJD also differs from that of classic CJD.

Kuru acquired prion disease was found exclusively among the Fore people of Papua New Guinea. It was transmitted through ritualistic funerary cannibalism, where individuals consumed the brains of deceased relatives. The primary symptom is severe ataxia. With the cessation of this practice in the 1950s, Kuru has been virtually eradicated.

Gerstmann-Sträussler-Scheinker Syndrome (GSS) is an extremely rare, inherited prion disease caused by a specific mutation in the prion protein gene. It typically has an earlier onset and a slower progression than CJD, sometimes lasting for several years. The dominant symptom is usually ataxia, with dementia appearing later in the illness.

Fatal Familial Insomnia (FFI) is another rare, hereditary prion disease resulting from a specific genetic mutation. As its name suggests, its hallmark symptom is a severe and progressive insomnia that leads to the breakdown of the sleep-wake cycle, accompanied by autonomic dysfunction. Dementia and motor symptoms develop as the disease advances. A sporadic form, known as Sporadic Fatal Insomnia (sFI), also exists but is even rarer.

The Causes of Prion Disease

The causes of prion disease are grouped into three distinct categories: sporadic, where the disease appears spontaneously with no known reason; hereditary, caused by an inherited genetic mutation; and acquired, resulting from transmission of infectious prions from an external source. This tripartite classification is unique among diseases and reflects the different ways the initial misfolding event of the prion protein can be triggered.

Although the underlying molecular mechanism, the propagation of misfolded PrP^Sc, is the same in all cases, the initial trigger differs significantly among these three etiologies. Approximately 85-90% of all cases are sporadic, 10-15% are hereditary, and less than 1% are acquired.

Sporadic Prion Disease

Sporadic prion disease is the most common form, occurring when a normal prion protein spontaneously misfolds into the pathogenic shape for reasons that are not yet understood. This initial misfolding event happens randomly, without any genetic predisposition or known exposure to an infectious agent. Once this first rogue prion is formed, it triggers the chain reaction of converting other normal proteins, leading to the onset of the disease.

Sporadic Creutzfeldt-Jakob Disease (sCJD) is the archetypal example and accounts for the vast majority of all human prion disease cases, with a worldwide incidence of about one to two cases per million people per year.

The leading hypothesis for sporadic prion disease is that the initial conversion of PrP^C to PrP^Sc is a rare, stochastic (random) event. It’s thought that the normal prion protein may occasionally misfold as part of a natural, but extremely infrequent, conformational error. In most instances, the cell’s quality control mechanisms would likely detect and degrade this misfolded protein. However, if this system fails, the single PrP^Sc molecule can begin the self-propagating cascade.

An alternative theory suggests that a somatic mutation, a genetic mutation that is not inherited but occurs in a single cell in the body during a person’s lifetime, could happen in the PRNP gene of a brain cell. This mutation could make the resulting prion protein unstable and more prone to misfolding, thereby initiating the disease process in that cell.

Also, a key aspect of sporadic prion disease is the absence of identifiable risk factors. It affects men and women equally, and it does not appear to be linked to diet, occupation, or lifestyle. The peak age of onset is typically between 60 and 70 years old, suggesting that age-related changes in cellular protein handling might play a role, but the precise trigger remains one of the greatest mysteries in prion biology.

Hereditary Prion Disease

Hereditary prion disease, also known as genetic or familial prion disease, is caused by an inherited mutation in the prion protein gene (PRNP), which is located on chromosome 20. This mutation makes the prion protein (PrP^C) structurally unstable and more likely to spontaneously misfold into the pathogenic PrP^Sc form.

Individuals who inherit this mutation have a significantly increased lifetime risk of developing a prion disease. These diseases are inherited in an autosomal dominant pattern, meaning that a child of an affected parent has a 50% chance of inheriting the mutated gene. Hereditary forms account for about 10-15% of all prion disease cases.

The PRNP gene provides the blueprint for making the normal prion protein. Over 50 different point mutations, insertions, or deletions in this gene have been identified that are linked to hereditary prion diseases. The specific type of mutation often influences the clinical presentation of the disease, including the age of onset, duration of illness, and the dominant symptoms.

Different mutations are associated with distinct disease entities. For example, the D178N mutation, when paired with a specific variation at another location in the gene (codon 129), causes Fatal Familial Insomnia (FFI). The same D178N mutation, when paired with a different variation at codon 129, typically leads to familial Creutzfeldt-Jakob Disease (fCJD). The P102L mutation is the most common cause of Gerstmann-Sträussler-Scheinker Syndrome (GSS).

The identification of these causative mutations allows for genetic testing to confirm a diagnosis in a symptomatic individual or for predictive testing in at-risk, asymptomatic family members. This raises complex ethical considerations, and genetic counseling is essential for individuals and families considering testing. It provides them with information about the implications of a positive test result, the inheritance pattern, and the lack of a cure or preventative treatment.

Acquired Prion Disease

Acquired prion disease occurs when an individual is exposed to infectious prions from an external source, which then triggers the disease process in their own brain. This is the rarest form of prion disease, accounting for less than 1% of all cases. Transmission requires direct contact with infected brain or nervous system tissue.

Unlike viruses or bacteria, prions are not contagious through casual contact, such as touching, coughing, or sneezing. The routes of transmission are very specific and have been linked to certain medical procedures or, in one notable instance, consumption of contaminated food.

Iatrogenic transmission refers to transmission through medical procedures. Historically, iatrogenic Creutzfeldt-Jakob Disease (iCJD) has been transmitted through contaminated neurosurgical instruments (prions are resistant to standard sterilization methods), dura mater grafts (a membrane that covers the brain), corneal transplants, and, most commonly, from human growth hormone (hGH) and gonadotropin derived from the pituitary glands of human cadavers before a synthetic version became available. These routes of transmission have now been largely eliminated due to improved sterilization techniques and the use of synthetic hormones.

As previously mentioned, Kuru was transmitted among the Fore people of Papua New Guinea through the ritualistic consumption of the brains of deceased relatives during mourning ceremonies. This direct oral route of exposure to high concentrations of prions in brain tissue led to a devastating epidemic.

Variant CJD (vCJD) form represents the only known instance of prion disease transmission from animals to humans through the food chain. The vCJD epidemic in the United Kingdom and other countries in the 1990s and 2000s was linked to eating beef products from cattle infected with bovine spongiform encephalopathy (BSE). Additionally, a small number of vCJD cases have been transmitted from person to person through blood transfusions from donors who were incubating the disease but were asymptomatic at the time of donation.

Prion Diseases Diagnosis

Diagnosing prion disease while a person is alive is a challenging process that relies on a combination of clinical observations and specialized tests, as a definitive diagnosis requires examining brain tissue obtained through a biopsy or autopsy. Neurologists typically begin with a thorough neurological exam and review of the patient’s medical history to assess the rapid progression of symptoms.

To rule out other conditions and find evidence of prion disease, several key diagnostic tools are employed. An electroencephalogram (EEG), which measures electrical activity in the brain, may show a characteristic pattern known as periodic sharp wave complexes in many patients with Creutzfeldt-Jakob disease (CJD).

Magnetic resonance imaging (MRI) scans of the brain are also crucial, often revealing specific abnormalities such as high signal intensity in the caudate nucleus, putamen, or cerebral cortex, sometimes referred to as cortical ribboning. The most specific diagnostic tests involve analyzing cerebrospinal fluid (CSF) obtained via a lumbar puncture (spinal tap).

The presence of certain proteins, such as the 14-3-3 protein, can be an indicator, but the most powerful test is the real-time quaking-induced conversion (RT-QuIC) assay, which can detect the minute amounts of the abnormal prion protein and has very high specificity and sensitivity for sporadic CJD.

Prion Disease vs. Alzheimer’s Disease

While both prion disease and Alzheimer’s disease are neurodegenerative conditions that cause dementia, they differ fundamentally in their causative agents, speed of progression, and hallmark clinical features. The most striking difference is the velocity of decline; prion diseases like CJD are characterized by an extremely rapid progression, with patients often deteriorating from initial symptoms to death within a year, and sometimes in just a few months.

In stark contrast, Alzheimer’s disease is a slow, insidious illness that typically progresses over many years, or even decades. The underlying pathology is also distinct. Prion diseases are caused by the misfolding of the native prion protein (PrP), which triggers a chain reaction that destroys brain tissue, leading to a “spongiform” or sponge-like appearance under a microscope.

Alzheimer’s, on the other hand, is associated with the accumulation of beta-amyloid plaques outside of neurons and tau tangles within them. Although both involve protein misfolding, the specific proteins and the mechanism of propagation are entirely different.

Comparing their clinical presentations highlights further distinctions that aid in differential diagnosis. These differences are critical for neurologists to identify, as they guide the diagnostic pathway and care planning.

How to Prevent Prion Disease

The ability to prevent prion disease is almost entirely limited to its acquired forms, as sporadic and genetic types are not currently preventable. Sporadic prion diseases, such as sporadic CJD, account for the vast majority of cases (about 85%) and occur without any known reason, meaning there are no risk factors to mitigate or lifestyle changes to make for prevention.

Similarly, familial or genetic prion diseases, which result from inherited mutations in the prion protein gene (PRNP), cannot be prevented from developing in individuals who carry the mutation. For families with a known history, genetic counseling can provide information about the risk of inheritance and options for family planning, but it does not prevent the disease itself in carriers.

In contrast, acquired prion diseases, which are transmitted through exposure to infected tissue or contaminated materials, are extremely rare but largely preventable through strict public health measures. These measures were developed in response to past outbreaks and are critical for safeguarding public health.

The primary strategies for preventing acquired prion diseases focus on breaking the chain of transmission. These strategies have been highly effective in minimizing new cases and are enforced globally.

Iatrogenic CJD (iCJD) was historically transmitted through contaminated neurosurgical instruments, cornea transplants, or human-derived growth hormone. To prevent this, healthcare facilities now adhere to extremely rigorous sterilization protocols that can inactivate prions, such as using a combination of chemical treatments and autoclaving at high temperatures and pressures. Many neurosurgical instruments are now single-use.

Variant CJD (vCJD) is linked to the consumption of beef from cattle infected with bovine spongiform encephalopathy (BSE), or “mad cow disease.” Prevention relies on strict regulations in the agricultural industry, including banning the use of mammalian protein in cattle feed, rigorous surveillance and testing of cattle for BSE, and the removal of high-risk tissues (like the brain and spinal cord) from the food supply.

To prevent potential transmission of vCJD through blood transfusions, many countries have implemented restrictions on blood donations from individuals who lived in or traveled extensively to regions with high BSE prevalence during specific time periods, such as the United Kingdom in the 1980s and 1990s.

Prognosis for Someone With Prion Disease

The prognosis for any form of prion disease is universally grim, as these conditions are untreatable, relentlessly progressive, and always fatal. Following the onset of symptoms, patients experience a rapid and devastating decline in cognitive and motor function. The speed of progression is a defining characteristic of these diseases.

For sporadic Creutzfeldt-Jakob disease (CJD), the most common human prion disease, the median survival time is only about four to six months from the onset of symptoms. Approximately 90% of individuals diagnosed with sporadic CJD die within one year. Other forms, such as the genetic types like fatal familial insomnia (FFI) or Gerstmann-Sträussler-Scheinker syndrome (GSS), may have a slightly longer duration, but the outcome remains the same.

The final stages of the illness are marked by severe neurological impairment, where the patient becomes bedridden, unable to communicate, and completely dependent on others for care. Death typically results from complications such as pneumonia or other infections due to immobility.

Given that there is no cure or effective treatment to slow the progression of prion diseases, medical care is exclusively focused on comfort and quality of life. This approach is known as palliative care or supportive care. The goal is to manage the distressing symptoms that arise as the disease advances.

FAQs

1. How can you protect yourself from prion diseases?

There is no guaranteed way to prevent all prion diseases because most cases occur spontaneously without a known cause. However, the risk of acquired prion disease is extremely low.

Public health measures, including strict screening of blood donations, careful sterilization of certain medical instruments, and regulations on livestock feed and food safety, have greatly reduced the risk of transmission. If you have a family history of inherited prion disease, genetic counseling may be recommended.

2. Is prion disease 100% fatal?

At present, prion diseases are considered fatal. While supportive treatments may help manage symptoms and improve comfort, there is currently no cure or therapy that can stop or reverse the progression of the disease. Researchers continue to study potential treatments, but none have yet been proven to cure prion disease.

3. What meat do prions come from?

Prions associated with variant Creutzfeldt-Jakob disease (vCJD) have been linked to consuming beef products from cattle affected by bovine spongiform encephalopathy (BSE), also known as mad cow disease. Today, strict food safety regulations and surveillance programs have made this route of transmission extremely rare in many countries.

4. What celebrities have prion disease?

Several well-known individuals have been reported to have died from prion diseases, including George H. W. Bush’s daughter, Robin Bush, who died from leukemia rather than prion disease, so she is not an example.

A commonly cited public figure who died from a confirmed prion disease is Terry Pratchett, although his illness was Posterior cortical atrophy, not a prion disease. One well-documented example is José Baselga, who died from Creutzfeldt-Jakob disease in 2021. Because prion diseases are extremely rare, confirmed public cases are uncommon.

5. How long can you live with prion disease?

Survival depends on the specific type of prion disease. For the most common form, sporadic Creutzfeldt-Jakob disease, many patients live about 6 to 12 months after symptoms begin, although some may survive for a shorter or longer period. Other forms of prion disease can progress at different rates.

6. How rare is getting prion disease?

Prion diseases are among the rarest neurological disorders. They affect approximately 1 to 2 people per million worldwide each year. Although they receive significant attention because of their severity, the likelihood of developing a prion disease is extremely low for the general population.

Conclusion

Prion diseases are rare but devastating neurological disorders that progress rapidly and have a profound impact on thinking, movement, and daily functioning. Because the earliest symptoms may resemble other neurological conditions, recognizing the prion disease symptoms can help prompt timely medical evaluation and appropriate diagnostic testing.

Although there is currently no cure, an early diagnosis can help rule out other treatable conditions, guide supportive care, and provide patients and their families with access to specialized medical services and planning resources. Symptoms such as rapidly worsening memory loss, personality changes, coordination problems, muscle jerks, or difficulty speaking and walking should never be ignored.

While the risk of developing a prion disease is extremely low, awareness remains important. If you or a loved one experiences persistent or rapidly progressing neurological symptoms, consult a healthcare professional for a thorough evaluation. Early assessment is the best way to identify the cause and ensure the most appropriate care and support.

References

Disclaimer This article is intended for informational and educational purposes only. We are not medical professionals, and this content does not replace professional medical advice, diagnosis, or treatment. We aim to provide reliable resources to help you understand various health conditions and their causes. If you are experiencing persistent, severe, or concerning symptoms, you should seek guidance from a qualified healthcare provider. Read the full Disclaimer here →